Cargando…

Current and Emerging Pharmacotherapies for Primary CNS Lymphoma

Primary central nervous system lymphoma (PCNSL) constitutes a rare group of extranodal non-Hodgkin’s lymphoma (NHL) primarily of B cell origin. It occurs in both immuno-competent and immune-compromised patients. High dose m ethotrexate (HD-MTX) based chemotherapy is the standard therapy. Chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prodduturi, Prathima, Bierman, Philip J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362327/ https://www.ncbi.nlm.nih.gov/pubmed/22654527 http://dx.doi.org/10.4137/CMO.S7752

Ejemplares similares

Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies
por: Holdhoff, Matthias, et al.
Publicado: (2020)

Pharmacotherapy for uveitis: current management and emerging therapy
por: Barry, Robert J, et al.
Publicado: (2014)

Current and Emerging Pharmacotherapy for Fibromyalgia
por: Tzadok, Roie, et al.
Publicado: (2020)

Primary CNS Lymphoma
por: Phillips, Elizabeth H., et al.
Publicado: (2014)

Update on Novel Therapeutics for Primary CNS Lymphoma
por: Schaff, Lauren R., et al.
Publicado: (2021)

Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring
por: Chiavazza, C., et al.
Publicado: (2018)

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin’s Lymphoma: Focus on Brentuximab Vedotin
por: Furtado, Michelle, et al.
Publicado: (2012)

Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
por: Seidel, Clemens, et al.
Publicado: (2021)

SL3 PRIMARY CNS LYMPHOMA: CURRENT CONCEPTS AND THERAPEUTIC PERSPECTIVES
por: Grommes, Christian
Publicado: (2019)

Current Trends in the Pharmacotherapy of Cataracts
por: Heruye, Segewkal H., et al.
Publicado: (2020)

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2021)

Current and Emerging Pharmacotherapies for the Treatment of Relapsed Small Cell Lung Cancer
por: Nair, Binu S., et al.
Publicado: (2011)

An audit on the diagnosis of primary CNS lymphoma
por: Joe, Dorothy, et al.
Publicado: (2021)

Primary CNS Lymphoma Masquerading as Ventriculitis
por: Rohatgi, Shalesh, et al.
Publicado: (2022)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2020)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2021)

Relapse pattern and prognosis of primary CNS lymphoma
por: Dahiya, Saurabh, et al.
Publicado: (2012)

Pharmacotherapy of Sexual Dysfunctions : Current Status
por: Avasthi, Ajith, et al.
Publicado: (2004)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Sex-Specific Differences in Primary CNS Lymphoma
por: Roetzer, Thomas, et al.
Publicado: (2020)

Current and emerging therapies for primary central nervous system lymphoma
por: Yuan, Yan, et al.
Publicado: (2021)

Current Long-Term Pharmacotherapies for the Management of Obesity
por: Kim, Bo-Yeon, et al.
Publicado: (2020)

Pharmacotherapies for Obesity: Past, Current, and Future Therapies
por: Ioannides-Demos, Lisa L., et al.
Publicado: (2011)

Emerging Pharmacotherapies for Diabetic Macular Edema
por: Javey, Golnaz, et al.
Publicado: (2012)

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
por: Aldoss, Ibrahim T, et al.
Publicado: (2009)

Emerging pharmacotherapy for cancer patients with cognitive dysfunction
por: Davis, Justin, et al.
Publicado: (2013)

Current and emerging treatment options in primary mediastinal B-cell lymphoma
por: Fakhri, Bita, et al.
Publicado: (2021)

Emergent management with favorable outcome of an unusual presentation of a primary CNS lymphoma in an immunocompetent patient
por: Rao, Arun S., et al.
Publicado: (2014)

Multiparametric MR Imaging Features of Primary CNS Lymphomas
por: Talybov, Rustam, et al.
Publicado: (2022)

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
por: Heming, Michael, et al.
Publicado: (2022)

IL-4 CHALLENGES FOR MANAGEMENT OF PRIMARY CNS LYMPHOMA
por: Nagane, Motoo
Publicado: (2022)

Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
por: Cheong, Siew Lee, et al.
Publicado: (2022)

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges
por: Brandfon, Skyler, et al.
Publicado: (2023)

Obesity pharmacotherapy: current status
por: Kumar, Parveen, et al.
Publicado: (2015)

Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia
por: Lee, Lydia, et al.
Publicado: (2012)

Selective review and commentary on emerging pharmacotherapies for opioid addiction
por: Ling, Walter, et al.
Publicado: (2011)

Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
por: Bernatoniene, Jurga, et al.
Publicado: (2023)

Emerging Trend in the Pharmacotherapy of Osteoarthritis
por: Zhang, Wei, et al.
Publicado: (2019)

Emerging pharmacotherapies for COVID-19
por: Salvi, Rachana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fv1c5f2dik09i4mgehn1kbg3hf